2022
DOI: 10.1002/ardp.202200434
|View full text |Cite
|
Sign up to set email alerts
|

Novel benzenesulfonamide‐thiouracil conjugates with a flexible N‐ethyl acetamide linker as selective CA IX and CA XII inhibitors

Abstract: Novel benzenesulfonamide derivatives linked to diverse functionalized thiouracils through a flexible N-ethyl acetamide linker were designed and synthesized as carbonic anhydrase (CA) inhibitors. The synthesized candidates demonstrated a potent inhibitory activity against four different CA isoforms in the nanomolar range.Compound 10d showed more than twofold higher potency than the reference AAZ against CA II with K i of 5.65 and 12 nM, respectively. Moreover, compounds 10d and 20 revealed potent activity again… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…Quinazoline is an aromatic heterocyclic scaffold consisting of fused pyrimidine and a benzene ring. The quinazoline motif is considered to be one of the most important heterocyclic ring systems in pharmaceutical chemistry, present in many compounds and endowed with tremendous biological activities [ 9 , 10 , 11 , 12 ]. The quinazoline nucleus and its derivatives were reported to have significant potential as promising enzyme inhibitors ( Figure 1 ).…”
Section: Introductionmentioning
confidence: 99%
“…Quinazoline is an aromatic heterocyclic scaffold consisting of fused pyrimidine and a benzene ring. The quinazoline motif is considered to be one of the most important heterocyclic ring systems in pharmaceutical chemistry, present in many compounds and endowed with tremendous biological activities [ 9 , 10 , 11 , 12 ]. The quinazoline nucleus and its derivatives were reported to have significant potential as promising enzyme inhibitors ( Figure 1 ).…”
Section: Introductionmentioning
confidence: 99%